• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对新冠肺炎疫情的严格封锁与灵活社交距离策略:一项成本效益分析。

Strict Lockdown versus Flexible Social Distance Strategy for COVID-19 Disease: a Cost-Effectiveness Analysis.

作者信息

Mol Ben W, Karnon Jonathan

机构信息

Department of Obstetrics and Gynaecology, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.

Flinders Health and Medical Research Institute, Adelaide, South Australia, Australia.

出版信息

Arch Clin Biomed Res. 2023;7(1):58-63. doi: 10.26502/acbr.50170319. Epub 2023 Feb 1.

DOI:10.26502/acbr.50170319
PMID:37009074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10065462/
Abstract

OBJECTIVES

To balance the costs and effects comparing a strict lockdown versus a flexible social distancing strategy for societies affected by Coronavirus-19 Disease (COVID-19).

DESIGN

Cost-effectiveness analysis.

PARTICIPANTS

We used societal data and COVID-19 mortality rates from the public domain.

INTERVENTIONS

The intervention was a strict lockdown strategy that has been followed by Denmark. Reference strategy was flexible social distancing policy as was applied by Sweden. We derived mortality rates from COVID-19 national statistics, assumed the expected life years lost from each COVID-19 death to be 11 years and calculated lost life years until 31 August 2020. Expected economic costs were derived from gross domestic productivity (GDP) statistics from each country's official statistics bureau and forecasted GDP. The incremental financial costs of the strict lockdown were calculated by comparing Sweden with Denmark using externally available market information. Calculations were projected per one million inhabitants. In sensitivity analyses we varied the total cost of the lockdown (range -50% to +100%).

MAIN OUTCOME MEASURE

Financial costs per life years saved.

RESULTS

In Sweden, the number of people who died with COVID-19 was 577 per million inhabitants, resulting in an estimated 6,350 life years lost per million inhabitants. In Denmark, where a strict lockdown strategy was installed for months, the number of people dying with COVID-19 was on average 111 per million, resulting in an estimated 1,216 life years per million inhabitants lost. The incremental costs of strict lockdown to save one life year was US$ 137,285, and higher in most of the sensitivity analyses.

CONCLUSIONS

Comparisons of public health interventions for COVID-19 should take into account life years saved and not only lost lives. Strict lockdown costs more than US$ 130,000 per life year saved. As our all our assumptions were in favour of strict lockdown, a flexible social distancing policy in response to COVID19 is defendable.

摘要

目标

对于受冠状病毒病(COVID-19)影响的社会,比较严格封锁与灵活社交距离策略的成本和效果,以实现两者的平衡。

设计

成本效益分析。

参与者

我们使用了来自公共领域的社会数据和COVID-19死亡率。

干预措施

干预措施是丹麦所采用的严格封锁策略。参考策略是瑞典实施的灵活社交距离政策。我们从COVID-19国家统计数据中得出死亡率,假设每例COVID-19死亡导致的预期寿命损失为11年,并计算截至2020年8月31日的寿命损失年数。预期经济成本来自各国官方统计局的国内生产总值(GDP)统计数据和预测的GDP。通过利用外部可得的市场信息,将瑞典与丹麦进行比较,计算出严格封锁的增量财务成本。计算按每百万居民进行。在敏感性分析中,我们改变了封锁的总成本(范围为-50%至+100%)。

主要结局指标

每挽救一个生命年的财务成本。

结果

在瑞典,每百万居民中死于COVID-19的人数为577人,导致每百万居民估计损失6350个生命年。在丹麦,实施了数月严格封锁策略,每百万居民中死于COVID-19的人数平均为111人,导致每百万居民估计损失1216个生命年。严格封锁挽救一个生命年的增量成本为137285美元,在大多数敏感性分析中更高。

结论

对COVID-19公共卫生干预措施的比较应考虑挽救的生命年数,而不仅仅是死亡人数。严格封锁每挽救一个生命年的成本超过13万美元。由于我们所有的假设都有利于严格封锁,因此应对COVID-19采取灵活的社交距离政策是合理的。

相似文献

1
Strict Lockdown versus Flexible Social Distance Strategy for COVID-19 Disease: a Cost-Effectiveness Analysis.针对新冠肺炎疫情的严格封锁与灵活社交距离策略:一项成本效益分析。
Arch Clin Biomed Res. 2023;7(1):58-63. doi: 10.26502/acbr.50170319. Epub 2023 Feb 1.
2
Cost Benefit Analysis of Limited Reopening Relative to a Herd Immunity Strategy or Shelter in Place for SARS-CoV-2 in the United States.美国针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2),相对于群体免疫策略或就地避难措施而言有限度重新开放的成本效益分析。
medRxiv. 2020 Jun 28:2020.06.26.20141044. doi: 10.1101/2020.06.26.20141044.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
"Stay at Home, Protect the National Health Service, Save Lives": A cost benefit analysis of the lockdown in the United Kingdom.“居家隔离,保护国家医疗服务体系,拯救生命”:英国封城措施的成本效益分析。
Int J Clin Pract. 2021 Mar;75(3):e13674. doi: 10.1111/ijcp.13674. Epub 2020 Sep 21.
6
7
8
Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia.模拟澳大利亚维多利亚州新冠疫情政策对社会限制和封锁措施的反应与健康调整生命年和成本的关系。
JAMA Health Forum. 2021 Jul 30;2(7):e211749. doi: 10.1001/jamahealthforum.2021.1749. eCollection 2021 Jul.
9
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.瑞格列奈:对其在2型糖尿病治疗中应用的药物经济学综述
Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005.
10
COVID-19 Pandemic: Did Strict Mobility Restrictions Save Lives and Healthcare Costs in Maharashtra, India?新冠疫情:印度马哈拉施特拉邦实施的严格出行限制措施是否挽救了生命并降低了医疗成本?
Healthcare (Basel). 2023 Jul 24;11(14):2112. doi: 10.3390/healthcare11142112.

引用本文的文献

1
Cost-effectiveness of preventive COVID-19 interventions: a systematic review and network meta-analysis of comparative economic evaluation studies based on real-world data.2019冠状病毒病预防性干预措施的成本效益:基于真实世界数据的比较经济评估研究的系统评价与网络荟萃分析
J Glob Health. 2025 Feb 21;15:04017. doi: 10.7189/jogh.15.04017.
2
Cost-Effectiveness of the COVID-19 Test, Trace and Isolate Program in Colombia.哥伦比亚新冠病毒检测、追踪与隔离计划的成本效益
Lancet Reg Health Am. 2022 Feb;6:100109. doi: 10.1016/j.lana.2021.100109. Epub 2021 Nov 1.

本文引用的文献

1
COVID-19 - exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study.2019冠状病毒病——探究长期病症类型和共病程度对寿命损失年数的影响:一项建模研究
Wellcome Open Res. 2021 Mar 1;5:75. doi: 10.12688/wellcomeopenres.15849.3. eCollection 2020.
2
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.羟考酮治疗对严重 COVID-19 患者死亡率和器官支持的影响:REMAP-CAP COVID-19 皮质类固醇随机临床试验。
JAMA. 2020 Oct 6;324(13):1317-1329. doi: 10.1001/jama.2020.17022.
3
Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters.大流行中心非老年人群和非老年无基础疾病人群的 COVID-19 总体人群死亡率风险。
Environ Res. 2020 Sep;188:109890. doi: 10.1016/j.envres.2020.109890. Epub 2020 Jul 1.
4
Recessions and Health: The Long-Term Health Consequences of Responses to the Coronavirus.经济衰退与健康:应对新冠病毒的长期健康后果
Fisc Stud. 2020 Jun;41(2):337-344. doi: 10.1111/1475-5890.12230. Epub 2020 Jul 6.
5
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
6
The invisible pandemic.无形的大流行。
Lancet. 2020 May 30;395(10238):e98. doi: 10.1016/S0140-6736(20)31035-7. Epub 2020 May 5.
7
Shielding from covid-19 should be stratified by risk.对新冠病毒的防护应按风险分层。
BMJ. 2020 May 28;369:m2063. doi: 10.1136/bmj.m2063.
8
Preventing spread of SARS-CoV-2 and preparing for the COVID-19 outbreak in the surgical department: perspectives from two Scandinavian countries.预防严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播及外科应对新型冠状病毒肺炎(COVID-19)疫情的准备工作:来自两个斯堪的纳维亚国家的观点
J Surg Case Rep. 2020 May 6;2020(5):rjaa131. doi: 10.1093/jscr/rjaa131. eCollection 2020 May.
9
Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands.荷兰在新冠疫情期间癌症诊断病例减少。
Lancet Oncol. 2020 Jun;21(6):750-751. doi: 10.1016/S1470-2045(20)30265-5. Epub 2020 Apr 30.
10
Rehabilitation After Critical Illness in People With COVID-19 Infection.COVID-19 感染者的重症后康复。
Am J Phys Med Rehabil. 2020 Jun;99(6):470-474. doi: 10.1097/PHM.0000000000001443.